--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 19.8100
- +0.8100+4.26%
Trading Nov 21 11:01 ET
104.55MMarket Cap-10005P/E (TTM)
20.0000High19.0300Low26.35KVolume19.0300Open19.0000Pre Close518.32KTurnover1.06%Turnover RatioLossP/E (Static)5.28MShares38.500052wk High21.14P/B49.47MFloat Cap1.369552wk Low--Dividend TTM2.50MShs Float240.0000Historical High--Div YieldTTM5.11%Amplitude1.3695Historical Low19.6690Avg Price1Lot Size
Monopar Therapeutics Key Stats
Monopar Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Monopar Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data